| Kynurenine pathway in depression: A systematic review and meta-analysis K Ogyu, K Kubo, Y Noda, Y Iwata, S Tsugawa, Y Omura, M Wada, ... Neuroscience & Biobehavioral Reviews 90, 16-25, 2018 | 239 | 2018 |
| Kynurenic acid in schizophrenia: a systematic review and meta-analysis E Plitman, Y Iwata, F Caravaggio, S Nakajima, JK Chung, P Gerretsen, ... Schizophrenia bulletin 43 (4), 764-777, 2017 | 209 | 2017 |
| Glutamate-mediated excitotoxicity in schizophrenia: a review E Plitman, S Nakajima, C de la Fuente-Sandoval, P Gerretsen, ... European Neuropsychopharmacology 24 (10), 1591-1605, 2014 | 177 | 2014 |
| Glutamatergic neurometabolite levels in patients with ultra-treatment-resistant schizophrenia: a cross-sectional 3T proton magnetic resonance spectroscopy study Y Iwata, S Nakajima, E Plitman, F Caravaggio, J Kim, P Shah, W Mar, ... Biological psychiatry 85 (7), 596-605, 2019 | 109 | 2019 |
| Effects of glutamate positive modulators on cognitive deficits in schizophrenia: a systematic review and meta-analysis of double-blind randomized controlled trials Y Iwata, S Nakajima, T Suzuki, RSE Keefe, E Plitman, JK Chung, ... Molecular psychiatry 20 (10), 1151-1160, 2015 | 106 | 2015 |
| Neuroimaging findings in treatment-resistant schizophrenia: a systematic review: lack of neuroimaging correlates of treatment-resistant schizophrenia S Nakajima, H Takeuchi, E Plitman, G Fervaha, P Gerretsen, ... Schizophrenia research 164 (1-3), 164-175, 2015 | 103 | 2015 |
| Insight and medication adherence in schizophrenia: An analysis of the CATIE trial J Kim, M Ozzoude, S Nakajima, P Shah, F Caravaggio, Y Iwata, ... Neuropharmacology 168, 107634, 2020 | 92 | 2020 |
| Glutamatergic and GABAergic metabolite levels in schizophrenia-spectrum disorders: a meta-analysis of 1H-magnetic resonance spectroscopy studies T Nakahara, S Tsugawa, Y Noda, F Ueno, S Honda, M Kinjo, H Segawa, ... Molecular psychiatry 27 (1), 744-757, 2022 | 76 | 2022 |
| Reduced Insulin Sensitivity Is Related to Less Endogenous Dopamine at D2/3 Receptors in the Ventral Striatum of Healthy Nonobese Humans F Caravaggio, C Borlido, M Hahn, Z Feng, G Fervaha, P Gerretsen, ... International Journal of Neuropsychopharmacology 18 (7), pyv014, 2015 | 76 | 2015 |
| The impact of delay in clozapine initiation on treatment outcomes in patients with treatment-resistant schizophrenia: a systematic review P Shah, Y Iwata, E Plitman, EE Brown, F Caravaggio, J Kim, S Nakajima, ... Psychiatry research 268, 114-122, 2018 | 75 | 2018 |
| Glutathione levels and activities of glutathione metabolism enzymes in patients with schizophrenia: A systematic review and meta-analysis S Tsugawa, Y Noda, R Tarumi, Y Mimura, K Yoshida, Y Iwata, M Elsalhy, ... Journal of Psychopharmacology 33 (10), 1199-1214, 2019 | 66 | 2019 |
| Lifetime history of depression predicts increased amyloid-β accumulation in patients with mild cognitive impairment JK Chung, E Plitman, S Nakajima, TW Chow, MM Chakravarty, ... Journal of Alzheimer's Disease 45 (3), 907-919, 2015 | 64 | 2015 |
| Neurometabolite levels in antipsychotic-naïve/free patients with schizophrenia: A systematic review and meta-analysis of 1H-MRS studies Y Iwata, S Nakajima, E Plitman, Y Mihashi, F Caravaggio, JK Chung, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 86, 340-352, 2018 | 59 | 2018 |
| A meta-analysis of transcranial direct current stimulation for schizophrenia:“Is more better?” J Kim, Y Iwata, E Plitman, F Caravaggio, JK Chung, P Shah, ... Journal of psychiatric research 110, 117-126, 2019 | 53 | 2019 |
| Dopaminergic dysfunction and excitatory/inhibitory imbalance in treatment-resistant schizophrenia and novel neuromodulatory treatment M Wada, Y Noda, Y Iwata, S Tsugawa, K Yoshida, H Tani, Y Hirano, ... Molecular Psychiatry 27 (7), 2950-2967, 2022 | 52 | 2022 |
| Cortical amyloid β deposition and current depressive symptoms in Alzheimer disease and mild cognitive impairment JK Chung, E Plitman, S Nakajima, MM Chakravarty, F Caravaggio, ... Journal of geriatric psychiatry and neurology 29 (3), 149-159, 2016 | 49 | 2016 |
| Depressive symptoms and small hippocampal volume accelerate the progression to dementia from mild cognitive impairment JK Chung, E Plitman, S Nakajima, MM Chakravarty, F Caravaggio, ... Journal of Alzheimer's Disease 49 (3), 743-754, 2016 | 48 | 2016 |
| Anosognosia is an independent predictor of conversion from mild cognitive impairment to Alzheimer's disease and is associated with reduced brain metabolism P Gerretsen, JK Chung, P Shah, E Plitman, Y Iwata, F Caravaggio, ... The Journal of clinical psychiatry 78 (9), 805, 2017 | 43 | 2017 |
| Comparative efficacy between clozapine and other atypical antipsychotics on depressive symptoms in patients with schizophrenia: analysis of the CATIE phase 2E data S Nakajima, H Takeuchi, G Fervaha, E Plitman, JK Chung, F Caravaggio, ... Schizophrenia research 161 (2-3), 429-433, 2015 | 41 | 2015 |
| Clozapine response trajectories and predictors of non-response in treatment-resistant schizophrenia: a chart review study P Shah, Y Iwata, EE Brown, J Kim, M Sanches, H Takeuchi, S Nakajima, ... European Archives of Psychiatry and Clinical Neuroscience 270, 11-22, 2020 | 40 | 2020 |
